Ignite Creation Date:
2024-05-05 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00472433
Status:
TERMINATED
Last Update Posted:
2009-06-22
First Post:
2007-04-25
Brief Title:
The Efficacy and Safety of Alemtuzumab in Auotoimmune Cytopenias
Sponsor:
Phramongkutklao College of Medicine and Hospital
Organization:
Phramongkutklao College of Medicine and Hospital
Organization Data
Organization:
Phramongkutklao College of Medicine and Hospital
Class:
OTHER
Study ID:
TH011003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Phramongkutklao College of Medicine and Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bayer | INDUSTRY |